A carregar...
A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis(†)
BACKGROUND: Brain radiation necrosis (BRN) can be a complication of radiotherapy for primary and secondary brain tumors, as well as head and neck tumors. Since vascular endothelial growth factor (VEGF) is also a vascular permeability factor in the brain, bevacizumab, a humanized antibody that inhibi...
Na minha lista:
Publicado no: | Neurooncol Pract |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Oxford University Press
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5099992/ https://ncbi.nlm.nih.gov/pubmed/27833757 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npv064 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|